Colorectal cancer is the third most common cancer worldwide, accounting for more than
610,000 mortalities every year. Prognosis of patients is highly dependent on the disease …

Glypican 3 (GPC3), a membrane-bound heparan sulfate proteoglycan, is overexpressed in
approximately 70% to 80% of hepatocellular carcinomas, but is not expressed commonly in …

Background Colorectal adenocarcinoma with enteroblastic differentiation (CAED) is a rare
subtype of colorectal malignancy with expression of enteroblastic markers (glypican 3 …

Abstract Glypican‐3 (GPC3) is a cancer antigen expressed in approximately 80% of
hepatocellular carcinomas (HCC) and is secreted into the blood. To confirm the …

Neoadjuvant chemoradiotherapy has been widely used in the treatment of locally advanced
rectal cancer due to the excellent advantages of irradiation in cancer therapy. Unfortunately …

Abstract Introduction Glypican-3 (GPC3) is involved in regulation of cell proliferation and
morphogenesis. It is abundant in embryonic tissue, but limited in most adult tissues. GPC3 …

Glypican-3 (GPC3) is a cell membrane glycoprotein that regulates cell growth and
proliferation. Aberrant expression or distribution of GPC3 underlies developmental …

Globally, colorectal cancer (CRC) is in third place in the rank of malignant tumours. In
industrialised countries, CRC is second among causes of death related to malignancy [1] …

Introduction Mucinous colorectal carcinoma (MC) is a rare subtype of colorectal
adenocarcinoma known to be associated with bad prognosis. Lately, research has turned to …

Background: Inherited susceptibility is an important contributor to colorectal cancer risk, and
rare variants in key genes or pathways could account in part for the missing proportion of …